GMRS
VENTE TOTALE: 1 457 102 titres (~17 776 644,40 $ US)
- Insiders
- Loporcaro Nicola
- Total bought
- —
- Total sold
- $17,776,644
- Last activity
- 2026-09-14
- Last synced
-
2026-09-16 10:16:14
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bearish signal Scored 2026-09-15
The 0-100 score behind this signal and the full written analysis are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 |
|---|---|---|
| Gross Profit Margin | 38.9% | |
| Ebit Margin | 12.9% | |
| Ebitda Margin | 18.6% | |
| Operating Profit Margin | 14.4% | |
| Pretax Profit Margin | 5.5% | |
| Continuous Operations Profit Margin | 3.6% | |
| Net Profit Margin | 3.6% | |
| Bottom Line Profit Margin | 0.6% | |
| Current Ratio | 2.003 | |
| Quick Ratio | 1.894 | |
| Solvency Ratio | 0.074 | |
| Cash Ratio | 0.572 | |
| Price To Earnings Ratio | 87.375 | |
| Price To Earnings Growth Ratio | 0.000 | |
| Forward Price To Earnings Growth Ratio | 0.000 | |
| Price To Earnings Diluted Ratio | 87.375 | |
| Price To Earnings Diluted Growth Ratio | 0.000 | |
| Price To Book Ratio | 15.280 | |
| Price To Sales Ratio | 0.543 | |
| Price To Free Cash Flow Ratio | 8.154 | |
| Price To Operating Cash Flow Ratio | 4.866 | |
| Debt To Assets Ratio | 0.718 | |
| Debt To Equity Ratio | 26.311 | |
| Debt To Capital Ratio | 0.963 | |
| Long Term Debt To Capital Ratio | 0.960 | |
| Financial Leverage Ratio | 36.649 | |
| Working Capital Turnover Ratio | 0.000 | |
| Operating Cash Flow Ratio | 0.602 | |
| Operating Cash Flow Sales Ratio | 0.112 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.597 | |
| Debt Service Coverage Ratio | 1.682 | |
| Interest Coverage Ratio | 1.950 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.357 | |
| Operating Cash Flow Coverage Ratio | 0.119 | |
| Capital Expenditure Coverage Ratio | 2.480 | |
| Dividend Paid And Capex Coverage Ratio | 2.480 | |
| Dividend Payout Ratio | 0.000 | |
| Enterprise Value Multiple | 7.374 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 38.9% | n/a | 0.0% |
| Ebit Margin | 12.9% | n/a | 0.0% |
| Ebitda Margin | 18.6% | n/a | 0.0% |
| Operating Profit Margin | 14.4% | n/a | 0.0% |
| Pretax Profit Margin | 5.5% | n/a | 0.0% |
| Continuous Operations Profit Margin | 3.6% | n/a | 0.0% |
| Net Profit Margin | 3.6% | n/a | 0.0% |
| Bottom Line Profit Margin | 0.6% | n/a | 0.0% |
| Current Ratio | 2.003 | n/a | 0.000 |
| Quick Ratio | 1.894 | n/a | 0.000 |
| Solvency Ratio | 0.074 | n/a | 0.000 |
| Cash Ratio | 0.573 | n/a | 0.000 |
| Price To Earnings Ratio | 87.375 | n/a | 0.000 |
| Price To Earnings Growth Ratio | 0.000 | n/a | 0.000 |
| Forward Price To Earnings Growth Ratio | 0.000 | n/a | 0.000 |
| Price To Earnings Diluted Ratio | 87.375 | n/a | 0.000 |
| Price To Earnings Diluted Growth Ratio | 0.000 | n/a | 0.000 |
| Price To Book Ratio | 15.280 | n/a | 0.000 |
| Price To Sales Ratio | 0.543 | n/a | 0.000 |
| Price To Free Cash Flow Ratio | 8.153 | n/a | 0.000 |
| Price To Operating Cash Flow Ratio | 4.866 | n/a | 0.000 |
| Debt To Assets Ratio | 0.718 | n/a | 0.000 |
| Debt To Equity Ratio | 26.311 | n/a | 0.000 |
| Debt To Capital Ratio | 0.963 | n/a | 0.000 |
| Long Term Debt To Capital Ratio | 0.960 | n/a | 0.000 |
| Financial Leverage Ratio | 36.649 | n/a | 0.000 |
| Working Capital Turnover Ratio | 0.000 | n/a | 0.000 |
| Operating Cash Flow Ratio | 0.602 | n/a | 0.000 |
| Operating Cash Flow Sales Ratio | 0.112 | n/a | 0.000 |
| Free Cash Flow Operating Cash Flow Ratio | 0.597 | n/a | 0.000 |
| Debt Service Coverage Ratio | 1.682 | n/a | 0.000 |
| Interest Coverage Ratio | 1.950 | n/a | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 4.357 | n/a | 0.000 |
| Operating Cash Flow Coverage Ratio | 0.119 | n/a | 0.000 |
| Capital Expenditure Coverage Ratio | 2.480 | n/a | 0.000 |
| Dividend Paid And Capex Coverage Ratio | 2.480 | n/a | 0.000 |
| Dividend Payout Ratio | 0.000 | n/a | 0.000 |
| Enterprise Value Multiple | 7.374 | n/a | 0.000 |
Key metrics
| Metric | Trend | 2025 |
|---|---|---|
| Market cap | $3.12B | |
| Enterprise value | $7.88B | |
| EV / Sales | 1.37x | |
| EV / Op. cash flow | 12.29x | |
| EV / Free cash flow | 20.60x | |
| EV / EBITDA | 7.37x | |
| Net debt / EBITDA | 4.46x | |
| Current ratio | 2.00x | |
| Income quality | 3.11x | |
| Graham number | $4 | |
| Graham net-net | -$26 | |
| Tax burden | 65.2% | |
| Interest burden | 42.8% | |
| Working capital | $1.07B | |
| Invested capital | $6.10B | |
| Return on assets | 2.8% | |
| Operating ROA | 0.0% | |
| Return on tangible assets | 5.0% | |
| Return on equity | 101.0% | |
| Return on invested capital | 8.1% | |
| Return on capital employed | 12.8% | |
| Earnings yield | 6.6% | |
| Free cash flow yield | 12.3% | |
| Capex / Op. cash flow | 40.3% | |
| Capex / Depreciation | 78.4% | |
| Capex / Sales | 4.5% | |
| SG&A / Sales | 3.3% | |
| R&D / Sales | 0.0% | |
| Stock comp / Sales | 0.0% | |
| Intangibles / Total assets | 45.2% | |
| Days sales outstanding | 70d | |
| Days payables outstanding | 6d | |
| Operating cycle | 82d | |
| Cash conversion cycle | 75d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap 0.0%EV / Sales 0.0%EV / EBITDA 0.0%EV / Op. cash flow 0.000Earnings yield 0.000Graham number 0.000
Profitability
Return on equity 0.000Return on assets 0.000Return on invested capital 0.000Return on capital employed 0.000Operating ROA n/aIncome quality 0.000Tax burden 0.000
Efficiency
Days sales outstanding 0.000Days payables outstanding 0.000Operating cycle 0.000Cash conversion cycle 0.000Capex / Sales 0.000R&D / Sales n/a
Balance-sheet strength
Current ratio 0.000Net debt / EBITDA 0.000Working capital 0.000Invested capital 0.000Intangibles / Total assets 0.000
Change over 5 years
Valuation
Market cap 0.0%EV / Sales 0.0%EV / EBITDA 0.0%EV / Op. cash flow 0.000Earnings yield 0.000Graham number 0.000
Profitability
Return on equity 0.000Return on assets 0.000Return on invested capital 0.000Return on capital employed 0.000Operating ROA n/aIncome quality 0.000Tax burden 0.000
Efficiency
Days sales outstanding 0.000Days payables outstanding 0.000Operating cycle 0.000Cash conversion cycle 0.000Capex / Sales 0.000R&D / Sales n/a
Balance-sheet strength
Current ratio 0.000Net debt / EBITDA 0.000Working capital 0.000Invested capital 0.000Intangibles / Total assets 0.000
Employee count
No employee-count data synced.
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-09-14 GMR Solutions Inc. (GMRS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript GMR Solutions Inc. (GMRS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 2026-09-11 GMR Solutions Inc. Secures Commitments for Term Loan Repricing; Plans $200 Million Debt Paydown LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. (“GMR”) (NYSE: GMRS), the nation''s largest provider of emergency medical services, announced that Global Medical Response, Inc., the borrower under its first lien term loan, has obtained binding commitments to complete a repricing of its existing $2.9 billion Term Loan B facility due October 2032. In connection with the transaction, GMR expects to use approximately $200 million of cash on hand to repay outstanding term loan borrowings, redu.
- 2026-09-03 GMR Solutions Inc. to Present at September Conference LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. (NYSE: GMRS) the nation''s largest provider of emergency medical services, today announced that Company management will participate at the Morgan Stanley 24th Annual Global Healthcare Conference. Management will participate in a fireside chat on Sept. 14, 2026, at 1:50 p.m. ET. A link to the live and archived audio webcast will be made available on the “Events & Presentations” page of Global Medical Response''s Company''s investor relation.
- 2026-08-14 GMR Solutions Q2 Earnings Call Highlights GMR Solutions NYSE: GMRS reported second-quarter revenue growth and higher demand for its core emergency services, while adjusted EBITDA declined from the prior year as the company lapped favorable revenue estimate adjustments tied to older No Surprises Act claims and recorded IPO-related expenses.
- 2026-08-13 GMR Solutions Inc. (GMRS) Q2 2026 Earnings Call Transcript GMR Solutions Inc. (GMRS) Q2 2026 Earnings Call Transcript
- 2026-08-12 GMR Solutions Inc. (GMRS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates While the top- and bottom-line numbers for GMR Solutions Inc. (GMRS) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 2026-08-12 GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidance LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation''s largest provider of emergency medical services (“EMS”), today announced financial results for the three and six months ended June 30, 2026, and updated its full year 2026 financial guidance. “We are pleased with our second quarter results, which reflect operational execution and continued momentum across our business,” said Nick Loporcaro, Chairman and Chief Executive Officer at GMR. “We e.
- 2026-07-22 GMR Solutions Inc. Sets Second Quarter 2026 Earnings Call LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. Sets Second Quarter 2026 Earnings Call.
- 2026-07-08 GMR Solutions Strengthens Board with Appointments of Healthcare Leaders Dr. Amar Desai and Ellen Zane LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions, Inc. (NYSE: GMRS) (GMRS), the nation''s leading emergency medical services (EMS) provider, announced the appointments of Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026. The appointments bring decades of leadership experience across healthcare delivery, value-based care, health system operations, human capital management, and corporate governance, further strengthening the Board as Global Medical Response (GMR) ad.
- 2026-06-18 GMR Solutions: The Post-IPO Discount Looks Too Harsh GMR Solutions Inc. is rated a buy, leveraging national scale in EMS and trading at a discounted ~7.5x NTM P/E. GMRS''s scale enables contract wins, new market growth, and competitive renewal advantages, driving incremental revenue and margin optimization. Strategic focus on higher-acuity, better-reimbursed services and programs like Nurse Navigation is improving revenue quality and unit economics.